Everhart Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$597K Buy
1,545
+228
+17% +$84.6K 0.04% 246
2026
Q1
$386K Sell
1,317
-733
-36% -$241K 0.03% 319
2025
Q4
$719K Buy
2,050
+920
+81% +$311K 0.07% 210
2025
Q3
$365K Sell
1,130
-143
-11% -$44.5K 0.04% 288
2025
Q2
$495K Buy
1,273
+82
+7% +$33K 0.06% 222
2025
Q1
$518K Buy
+1,191
New +$478K 0.07% 201
2024
Q4
Sell
-1,384
Closed -$720K 318
2024
Q3
$720K Buy
1,384
+94
+7% +$50.2K 0.16% 145
2024
Q2
$699K Buy
1,290
+171
+15% +$90.4K 0.18% 119
2024
Q1
$580K Buy
1,119
+171
+18% +$85K 0.17% 126
2023
Q4
$447K Buy
948
+34
+4% +$15.7K 0.16% 128
2023
Q3
$398K Sell
914
-27
-3% -$12.2K 0.17% 115
2023
Q2
$418K Sell
941
-562
-37% -$259K 0.17% 115
2023
Q1
$691K Buy
1,503
+3
+0.2% +$1.43K 0.31% 67
2022
Q4
$770K Buy
1,500
+161
+12% +$81.7K 0.39% 54
2022
Q3
$608K Buy
1,339
+148
+12% +$70.8K 0.34% 58
2022
Q2
$575K Buy
1,191
+118
+11% +$58.4K 0.35% 63
2022
Q1
$527K Buy
1,073
+178
+20% +$81.4K 0.3% 70
2021
Q4
$415K Buy
+895
New +$377K 0.25% 75
2021
Q2
Sell
-610
Closed -$219K 98
2021
Q1
$219K Buy
+610
New +$196K 0.19% 74

Other funds holding ELV

Everhart Financial Group's ELV Position: Q2 2026 in Review

Everhart Financial Group increased its Elevance Health (ELV) stake by 17% in Q2 2026, buying an estimated $84.6K and bringing the position to 1,545 shares worth $597K. The position accounts for 0.04% of the portfolio, ranked #246.

Everhart Financial Group first reported a position in ELV in Q1 2021 and has held it in 19 quarters since. The position peaked at $770K in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Everhart Financial Group held 1,545 shares of Elevance Health worth $597K as of Q2 2026.
  • Everhart Financial Group bought 228 Elevance Health shares in Q2 2026, an estimated $84.6K.
  • Elevance Health made up 0.04% of Everhart Financial Group's portfolio in Q2 2026, its #246 holding.
  • Everhart Financial Group first reported a position in Elevance Health in Q1 2021 and has held it in 19 quarters since.
  • Everhart Financial Group's Elevance Health position peaked at $770K in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.